International Delphi-based consensus on the appropriate use and effect of Benzydamine hydrochloride in the treatment of sore throat

Abstract Background Benzydamine hydrochloride is a locally-acting Non-Steroidal Anti-Inflammatory Drug (NSAID) with combined local anesthetic and analgesic properties, indicated for the symptomatic relief of pain in acute sore throat. The aim of this study was to obtain an European Consensus among p...

Full description

Bibliographic Details
Main Authors: Desiderio Passali, Veronica Barat, Olga Cadevall, Hugo Miguel Freire, Ignazio Grattagliano, Ioan Gutu, Ralph Mösges, Andrey Pavlysh
Format: Article
Language:English
Published: BMC 2022-11-01
Series:BMC Primary Care
Subjects:
Online Access:https://doi.org/10.1186/s12875-022-01901-w
_version_ 1811186977480900608
author Desiderio Passali
Veronica Barat
Olga Cadevall
Hugo Miguel Freire
Ignazio Grattagliano
Ioan Gutu
Ralph Mösges
Andrey Pavlysh
author_facet Desiderio Passali
Veronica Barat
Olga Cadevall
Hugo Miguel Freire
Ignazio Grattagliano
Ioan Gutu
Ralph Mösges
Andrey Pavlysh
author_sort Desiderio Passali
collection DOAJ
description Abstract Background Benzydamine hydrochloride is a locally-acting Non-Steroidal Anti-Inflammatory Drug (NSAID) with combined local anesthetic and analgesic properties, indicated for the symptomatic relief of pain in acute sore throat. The aim of this study was to obtain an European Consensus among pharmacists, general practitioners and pediatricians on the appropriate use of benzydamine hydrochloride in the treatment of sore throat. Methods The authors developed a Delphi questionnaire organized into 15 statements focused on 4 topics: the mechanism of action of benzydamine, the benzydamine treatment in an adult patient and in a pediatric patient, and the advantages of benzydamine over other topical treatments. The survey was administered to a panel of to 320 participants including general practitioners, pediatricians, and pharmacists from 6 European countries (Italy, Germany, Portugal, Romania, Russia, and Spain), who rated their level of agreement or disagreement with each statement on a 6-point Likert scale. Consensus was predefined as more than 66% of the panel agreeing/disagreeing with each statement. Results Panelists’ agreement on statements was very high. Consensus was reached for all 15 statements in the Delphi survey, with more than 98% positive agreement on topic 4, suggesting a shared view among European healthcare professionals (HCPs) about the advantages of benzydamine over other topical treatments. A strong consensus (> 99%) was reached for all the statements of topic 1 regarding the mechanism of action of benzydamine, except for its anesthetic properties (79%). Strong agreement was reached for all statements in topics 2 and 3 regarding the treatment of acute sore throat symptoms in the adult and pediatric patient, except for one on the efficacy of benzydamine in preventing post-operative sore throat, for which it was 67%. Conclusion Because all relevant publications on benzydamine are dated and there are no recommendations on its use for the symptomatic treatment of sore throat in European guidelines, this Delphi-based international consensus may be important in reinforcing the appropriate use and effect of benzydamine in the treatment of sore throat among health care professionals.
first_indexed 2024-04-11T13:54:20Z
format Article
id doaj.art-de3ace296d764dc1ae69fa8d12170707
institution Directory Open Access Journal
issn 2731-4553
language English
last_indexed 2024-04-11T13:54:20Z
publishDate 2022-11-01
publisher BMC
record_format Article
series BMC Primary Care
spelling doaj.art-de3ace296d764dc1ae69fa8d121707072022-12-22T04:20:24ZengBMCBMC Primary Care2731-45532022-11-012311810.1186/s12875-022-01901-wInternational Delphi-based consensus on the appropriate use and effect of Benzydamine hydrochloride in the treatment of sore throatDesiderio Passali0Veronica Barat1Olga Cadevall2Hugo Miguel Freire3Ignazio Grattagliano4Ioan Gutu5Ralph Mösges6Andrey Pavlysh7International Federation ORL Societies (IFOS) Executive Board membersAOU Città della Salute e della Scienza di Torino, Regina Margherita Children’s HospitalClínica Rotger, QuirónsaludSociedade Portuguesa de Farmacêuticos dos Cuidados de SaúdeItalian College of General Practitioners and Primary CareGeneral PractitionerInstitute of Medical Statistics, and Computational Biology (IMSB), Medical Faculty, University at CologneNorth-Western State Medical University named after I.I. MechnikovAbstract Background Benzydamine hydrochloride is a locally-acting Non-Steroidal Anti-Inflammatory Drug (NSAID) with combined local anesthetic and analgesic properties, indicated for the symptomatic relief of pain in acute sore throat. The aim of this study was to obtain an European Consensus among pharmacists, general practitioners and pediatricians on the appropriate use of benzydamine hydrochloride in the treatment of sore throat. Methods The authors developed a Delphi questionnaire organized into 15 statements focused on 4 topics: the mechanism of action of benzydamine, the benzydamine treatment in an adult patient and in a pediatric patient, and the advantages of benzydamine over other topical treatments. The survey was administered to a panel of to 320 participants including general practitioners, pediatricians, and pharmacists from 6 European countries (Italy, Germany, Portugal, Romania, Russia, and Spain), who rated their level of agreement or disagreement with each statement on a 6-point Likert scale. Consensus was predefined as more than 66% of the panel agreeing/disagreeing with each statement. Results Panelists’ agreement on statements was very high. Consensus was reached for all 15 statements in the Delphi survey, with more than 98% positive agreement on topic 4, suggesting a shared view among European healthcare professionals (HCPs) about the advantages of benzydamine over other topical treatments. A strong consensus (> 99%) was reached for all the statements of topic 1 regarding the mechanism of action of benzydamine, except for its anesthetic properties (79%). Strong agreement was reached for all statements in topics 2 and 3 regarding the treatment of acute sore throat symptoms in the adult and pediatric patient, except for one on the efficacy of benzydamine in preventing post-operative sore throat, for which it was 67%. Conclusion Because all relevant publications on benzydamine are dated and there are no recommendations on its use for the symptomatic treatment of sore throat in European guidelines, this Delphi-based international consensus may be important in reinforcing the appropriate use and effect of benzydamine in the treatment of sore throat among health care professionals.https://doi.org/10.1186/s12875-022-01901-wSore throatBenzydamineOropharynxDelphi-based consensusGeneral practitionerPharmacists
spellingShingle Desiderio Passali
Veronica Barat
Olga Cadevall
Hugo Miguel Freire
Ignazio Grattagliano
Ioan Gutu
Ralph Mösges
Andrey Pavlysh
International Delphi-based consensus on the appropriate use and effect of Benzydamine hydrochloride in the treatment of sore throat
BMC Primary Care
Sore throat
Benzydamine
Oropharynx
Delphi-based consensus
General practitioner
Pharmacists
title International Delphi-based consensus on the appropriate use and effect of Benzydamine hydrochloride in the treatment of sore throat
title_full International Delphi-based consensus on the appropriate use and effect of Benzydamine hydrochloride in the treatment of sore throat
title_fullStr International Delphi-based consensus on the appropriate use and effect of Benzydamine hydrochloride in the treatment of sore throat
title_full_unstemmed International Delphi-based consensus on the appropriate use and effect of Benzydamine hydrochloride in the treatment of sore throat
title_short International Delphi-based consensus on the appropriate use and effect of Benzydamine hydrochloride in the treatment of sore throat
title_sort international delphi based consensus on the appropriate use and effect of benzydamine hydrochloride in the treatment of sore throat
topic Sore throat
Benzydamine
Oropharynx
Delphi-based consensus
General practitioner
Pharmacists
url https://doi.org/10.1186/s12875-022-01901-w
work_keys_str_mv AT desideriopassali internationaldelphibasedconsensusontheappropriateuseandeffectofbenzydaminehydrochlorideinthetreatmentofsorethroat
AT veronicabarat internationaldelphibasedconsensusontheappropriateuseandeffectofbenzydaminehydrochlorideinthetreatmentofsorethroat
AT olgacadevall internationaldelphibasedconsensusontheappropriateuseandeffectofbenzydaminehydrochlorideinthetreatmentofsorethroat
AT hugomiguelfreire internationaldelphibasedconsensusontheappropriateuseandeffectofbenzydaminehydrochlorideinthetreatmentofsorethroat
AT ignaziograttagliano internationaldelphibasedconsensusontheappropriateuseandeffectofbenzydaminehydrochlorideinthetreatmentofsorethroat
AT ioangutu internationaldelphibasedconsensusontheappropriateuseandeffectofbenzydaminehydrochlorideinthetreatmentofsorethroat
AT ralphmosges internationaldelphibasedconsensusontheappropriateuseandeffectofbenzydaminehydrochlorideinthetreatmentofsorethroat
AT andreypavlysh internationaldelphibasedconsensusontheappropriateuseandeffectofbenzydaminehydrochlorideinthetreatmentofsorethroat